![Kush Parmar](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Kush Parmar
Président chez
ENTRADA THERAPEUTICS, INC.
Fortune : - $ au 30/06/2026
Profil
Kush M.
Parmar is the founder of Immuneel Therapeutics Pvt Ltd., founded in 2018.
Dr. Parmar was the founder of Cruz Blanca Initiative, Inc., founded in 2000, and served as President.
Dr. Parmar is also the founder of Ensoma, Inc...
Dr. Parmar is Chairman at Entrada Therapeutics, Inc. since 2020, Director at Astellas Gene Therapies, Inc. since 2013, Independent Non-Executive Director at Syngene International Ltd. since 2021, Director at Rallybio LLC, Director at Rallybio Holdings LLC, Director at GlycoEra AG since 2022, Secretary & Director at Precede Biosciences, Inc., Managing Partner at 5AM Venture Management LLC since 2010, Managing Member at 5AM Partners V LLC, Advisor at Grace Science Foundation since 2014, Managing Member at 5AM Opportunities I GP LLC, and Managing Member at 5am Partners Vi LLC.
Former positions include Co-Chief Executive Officer & Director at 5:01 Acquisition Corp., Chairman at Homology Medicines, Inc. from 2015 to 2022, Director at Achaogen, Inc., Director at Arvinas Operations, Inc., Director at Envoy Therapeutics, Inc., Director at Cleave Therapeutics, Inc., Independent Director at Astellas Gene Therapies, Inc. from 2013 to 2018, Independent Director at scPharmaceuticals, Inc. from 2014 to 2018, Director at Pulmatrix, Inc., Independent Director at Arvinas, Inc. from 2013 to 2019, Independent Director at Vor Biopharma, Inc. from 2021 to 2023, Independent Director at Akouos, Inc. from 2017 to 2022, Independent Director at Rallybio Corp.
from 2018 to 2024, and Vice President-Strategy & Corporate Development at Novira Therapeutics LLC from 2012 to 2015.
Education includes a doctorate from Harvard University conferred in 2008, a doctorate from Massachusetts Institute of Technology conferred in 2010, an undergraduate degree from Princeton University conferred in 2002, and a doctorate from Harvard Medical School conferred in 2010.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 10/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Kush Parmar
| Sociétés | Poste | Début |
|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Président | 01/12/2020 |
| SYNGENE INTERNATIONAL LIMITED | Directeur/Membre du Conseil | 22/06/2021 |
| AUDENTES THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/07/2013 |
5AM Venture Management LLC
 5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Private Equity Investor | 01/01/2010 |
Ensoma, Inc.
 Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Fondateur | - |
Grace Science Foundation
 Grace Science Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development to cure NGLY1 deficiency | Consultant / Advisor | 01/06/2014 |
GlycoEra AG
 GlycoEra AG BiotechnologyHealth Technology Develops novel biologics to transform the treatment of autoimmune diseases | Directeur/Membre du Conseil | 12/07/2022 |
5am Partners Vi LLC | Corporate Officer/Principal | - |
5AM Opportunities I GP LLC | Corporate Officer/Principal | - |
| ░░░ ░░░░░░░░ ░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
| ░░░░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Anciens postes connus de Kush Parmar
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░ ░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Kush Parmar
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
32
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 32 |
|---|---|
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
Arvinas Operations, Inc.
 Arvinas Operations, Inc. BiotechnologyHealth Technology Develops protein degradation therapeutics for cancer and other diseases | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Syngene International Ltd.
 Syngene International Ltd. Miscellaneous Commercial ServicesCommercial Services Offers integrated discovery and development services | Commercial Services |
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
5AM Venture Management LLC
5AM Venture Management LLC Investment ManagersFinance 5AM Ventures invests in companies located in the US with an investment size ranging from $20 to $30 million. The firm targets companies operating in the fields of life sciences. It provides financing for early stage and corporate spin-out capital requirements and also makes co-investments. | Finance |
Novira Therapeutics LLC
 Novira Therapeutics LLC Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Envoy Therapeutics, Inc.
 Envoy Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines for treatment of neurological and psychiatric diseases | Health Technology |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cleave Therapeutics, Inc.
 Cleave Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company that develops medicine for oncology and neurodegeneration treatment | Health Technology |
Astellas Gene Therapies, Inc.
 Astellas Gene Therapies, Inc. BiotechnologyHealth Technology Develops and commercializes gene therapy products for patients with serious rare diseases | Health Technology |
scPharmaceuticals, Inc.
 scPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products to the cardiovascular and infectious diseases | Health Technology |
Cruz Blanca Initiative, Inc. | |
Pulmatrix, Inc.
 Pulmatrix, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for pulmonary disease | Health Technology |
Arvinas, Inc.
 Arvinas, Inc. BiotechnologyHealth Technology Engages in discovery, development and commercialization of therapies to degrade disease-causing proteins | Health Technology |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage genetic medicines company | Health Technology |
5AM Partners V LLC | |
Vor Biopharma, Inc.
 Vor Biopharma, Inc. BiotechnologyHealth Technology Engages in developing cell therapies | Health Technology |
Akouos, Inc.
 Akouos, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a genetic medicine company that develops adeno-associated viral vector-based gene therapies for sensorineural hearing loss | Commercial Services |
Grace Science Foundation
Grace Science Foundation Miscellaneous Commercial ServicesCommercial Services Engages in research and development to cure NGLY1 deficiency | Commercial Services |
Rallybio LLC
 Rallybio LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotech company that delivers groundbreaking therapies | Commercial Services |
Rallybio Holdings LLC
 Rallybio Holdings LLC Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
Entrada Therapeutics, Inc.
 Entrada Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics for rare neuromuscular diseases | Health Technology |
5AM Opportunities I GP LLC | |
5:01 Acquisition Corp.
 5:01 Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Ensoma, Inc.
Ensoma, Inc. Miscellaneous Commercial ServicesCommercial Services Provides management consulting services | Commercial Services |
Immuneel Therapeutics Pvt Ltd.
 Immuneel Therapeutics Pvt Ltd. Hospital/Nursing ManagementHealth Services Operates as a cancer treatment center | Health Services |
5am Partners Vi LLC | |
Rallybio Corp.
 Rallybio Corp. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company that engages in research, development and commercialization of therapies for patients with severe & rare diseases | Health Technology |
GlycoEra AG
GlycoEra AG BiotechnologyHealth Technology Develops novel biologics to transform the treatment of autoimmune diseases | Health Technology |
Precede Biosciences, Inc.
 Precede Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Offers liquid biopsy platform for drug development | Commercial Services |
